HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-MAR-19 6JLR TITLE CRYSTAL STRUCTURE OF WILD TYPE MNK2 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE SIGNAL-INTEGRATING KINASE 2,MNK2; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MKNK2, GPRK7, MNK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, PHOSPHORYLATION, INHIBITOR, MNK, KINASE DOMAIN, TRANSFERASE, KEYWDS 2 CANCER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.BABURAJENDRAN,J.HILL REVDAT 2 22-NOV-23 6JLR 1 REMARK REVDAT 1 12-FEB-20 6JLR 0 JRNL AUTH J.KWIATKOWSKI,B.LIU,S.PANG,N.H.B.AHMAD,G.WANG,A.POULSEN, JRNL AUTH 2 H.YANG,Y.R.POH,D.H.Y.TEE,E.ONG,P.RETNA,N.DINIE,P.KWEK, JRNL AUTH 3 J.L.K.WEE,V.MANOHARAN,C.B.LOW,P.G.SEAH,V.PENDHARKAR, JRNL AUTH 4 K.SANGTHONGPITAG,J.JOY,N.BABURAJENDRAN,A.E.JANSSON,K.NACRO, JRNL AUTH 5 J.HILL,T.H.KELLER,A.W.HUNG JRNL TITL STEPWISE EVOLUTION OF FRAGMENT HITS AGAINST MAPK INTERACTING JRNL TITL 2 KINASES 1 AND 2. JRNL REF J.MED.CHEM. V. 63 621 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31910010 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01582 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 10333 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.300 REMARK 3 R VALUE (WORKING SET) : 0.297 REMARK 3 FREE R VALUE : 0.351 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.670 REMARK 3 FREE R VALUE TEST SET COUNT : 483 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.2845 - 4.1803 0.98 3307 200 0.2696 0.3369 REMARK 3 2 4.1803 - 3.3197 0.99 3299 127 0.3405 0.3651 REMARK 3 3 3.3197 - 2.9005 0.99 3244 156 0.3483 0.4116 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.490 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 46.010 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JLR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1300011061. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.9.9.4 W9RSSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18914 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 56.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 78.9 REMARK 200 DATA REDUNDANCY : 5.870 REMARK 200 R MERGE (I) : 0.23000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 14.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.37 REMARK 200 R MERGE FOR SHELL (I) : 0.69800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2AC3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23% POLYACRYLIC ACID 5100, 2% 2-METHYL REMARK 280 -2,4-PENTANE DIOL, 100MM HEPES PH 7.7, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.13200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.06600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 24.06600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 48.13200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 70 REMARK 465 GLY A 232 REMARK 465 ILE A 233 REMARK 465 LYS A 234 REMARK 465 LEU A 235 REMARK 465 ASN A 236 REMARK 465 GLY A 237 REMARK 465 ASP A 238 REMARK 465 CYS A 239 REMARK 465 SER A 240 REMARK 465 PRO A 241 REMARK 465 ILE A 242 REMARK 465 SER A 243 REMARK 465 THR A 244 REMARK 465 PRO A 245 REMARK 465 GLU A 246 REMARK 465 LEU A 247 REMARK 465 LEU A 248 REMARK 465 THR A 249 REMARK 465 PRO A 250 REMARK 465 CYS A 251 REMARK 465 SER A 301 REMARK 465 ASP A 302 REMARK 465 CYS A 303 REMARK 465 GLY A 304 REMARK 465 TRP A 305 REMARK 465 ASP A 306 REMARK 465 ARG A 307 REMARK 465 GLY A 308 REMARK 465 GLU A 309 REMARK 465 ALA A 310 REMARK 465 CYS A 311 REMARK 465 GLY A 370 REMARK 465 CYS A 371 REMARK 465 ALA A 372 REMARK 465 PRO A 373 REMARK 465 GLU A 374 REMARK 465 ASN A 375 REMARK 465 THR A 376 REMARK 465 LEU A 377 REMARK 465 PRO A 378 REMARK 465 THR A 379 REMARK 465 PRO A 380 REMARK 465 MET A 381 REMARK 465 VAL A 382 REMARK 465 LEU A 383 REMARK 465 GLN A 384 REMARK 465 ARG A 385 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 71 OG REMARK 470 LEU A 90 CG CD1 CD2 REMARK 470 HIS A 95 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 117 CG CD CE NZ REMARK 470 ARG A 125 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 265 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 266 OG REMARK 470 GLU A 267 CG CD OE1 OE2 REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 470 CYS A 314 SG REMARK 470 LYS A 326 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CB ASP A 331 NZ LYS A 332 6765 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 85 173.16 -56.27 REMARK 500 ARG A 204 18.29 58.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BV9 A 401 DBREF 6JLR A 72 385 UNP Q9HBH9 MKNK2_HUMAN 72 385 SEQADV 6JLR GLY A 70 UNP Q9HBH9 EXPRESSION TAG SEQADV 6JLR SER A 71 UNP Q9HBH9 EXPRESSION TAG SEQRES 1 A 316 GLY SER THR ASP SER PHE SER GLY ARG PHE GLU ASP VAL SEQRES 2 A 316 TYR GLN LEU GLN GLU ASP VAL LEU GLY GLU GLY ALA HIS SEQRES 3 A 316 ALA ARG VAL GLN THR CYS ILE ASN LEU ILE THR SER GLN SEQRES 4 A 316 GLU TYR ALA VAL LYS ILE ILE GLU LYS GLN PRO GLY HIS SEQRES 5 A 316 ILE ARG SER ARG VAL PHE ARG GLU VAL GLU MET LEU TYR SEQRES 6 A 316 GLN CYS GLN GLY HIS ARG ASN VAL LEU GLU LEU ILE GLU SEQRES 7 A 316 PHE PHE GLU GLU GLU ASP ARG PHE TYR LEU VAL PHE GLU SEQRES 8 A 316 LYS MET ARG GLY GLY SER ILE LEU SER HIS ILE HIS LYS SEQRES 9 A 316 ARG ARG HIS PHE ASN GLU LEU GLU ALA SER VAL VAL VAL SEQRES 10 A 316 GLN ASP VAL ALA SER ALA LEU ASP PHE LEU HIS ASN LYS SEQRES 11 A 316 GLY ILE ALA HIS ARG ASP LEU LYS PRO GLU ASN ILE LEU SEQRES 12 A 316 CYS GLU HIS PRO ASN GLN VAL SER PRO VAL LYS ILE CYS SEQRES 13 A 316 ASP PHE ASP LEU GLY SER GLY ILE LYS LEU ASN GLY ASP SEQRES 14 A 316 CYS SER PRO ILE SER THR PRO GLU LEU LEU THR PRO CYS SEQRES 15 A 316 GLY SER ALA GLU TYR MET ALA PRO GLU VAL VAL GLU ALA SEQRES 16 A 316 PHE SER GLU GLU ALA SER ILE TYR ASP LYS ARG CYS ASP SEQRES 17 A 316 LEU TRP SER LEU GLY VAL ILE LEU TYR ILE LEU LEU SER SEQRES 18 A 316 GLY TYR PRO PRO PHE VAL GLY ARG CYS GLY SER ASP CYS SEQRES 19 A 316 GLY TRP ASP ARG GLY GLU ALA CYS PRO ALA CYS GLN ASN SEQRES 20 A 316 MET LEU PHE GLU SER ILE GLN GLU GLY LYS TYR GLU PHE SEQRES 21 A 316 PRO ASP LYS ASP TRP ALA HIS ILE SER CYS ALA ALA LYS SEQRES 22 A 316 ASP LEU ILE SER LYS LEU LEU VAL ARG ASP ALA LYS GLN SEQRES 23 A 316 ARG LEU SER ALA ALA GLN VAL LEU GLN HIS PRO TRP VAL SEQRES 24 A 316 GLN GLY CYS ALA PRO GLU ASN THR LEU PRO THR PRO MET SEQRES 25 A 316 VAL LEU GLN ARG HET BV9 A 401 21 HETNAM BV9 4-[5-(1-METHYLPYRAZOL-4-YL)PYRIDIN-3-YL]BENZAMIDE FORMUL 2 BV9 C16 H14 N4 O HELIX 1 AA1 ARG A 78 VAL A 82 1 5 HELIX 2 AA2 ILE A 122 CYS A 136 1 15 HELIX 3 AA3 ILE A 167 ARG A 174 1 8 HELIX 4 AA4 ASN A 178 LYS A 199 1 22 HELIX 5 AA5 LYS A 207 GLU A 209 5 3 HELIX 6 AA6 ALA A 258 PHE A 265 1 8 HELIX 7 AA7 SER A 266 ASP A 273 1 8 HELIX 8 AA8 ARG A 275 GLY A 291 1 17 HELIX 9 AA9 ALA A 313 GLY A 325 1 13 HELIX 10 AB1 SER A 338 LEU A 349 1 12 HELIX 11 AB2 ASP A 352 ARG A 356 5 5 HELIX 12 AB3 SER A 358 HIS A 365 1 8 SHEET 1 AA1 5 TYR A 83 LEU A 85 0 SHEET 2 AA1 5 ALA A 96 ASN A 103 -1 O ILE A 102 N GLN A 84 SHEET 3 AA1 5 GLU A 109 GLU A 116 -1 O ILE A 114 N ARG A 97 SHEET 4 AA1 5 ARG A 154 GLU A 160 -1 O LEU A 157 N LYS A 113 SHEET 5 AA1 5 LEU A 145 GLU A 151 -1 N PHE A 149 O TYR A 156 SHEET 1 AA2 3 GLY A 165 SER A 166 0 SHEET 2 AA2 3 ILE A 211 HIS A 215 -1 O CYS A 213 N GLY A 165 SHEET 3 AA2 3 GLN A 218 ILE A 224 -1 O LYS A 223 N LEU A 212 CISPEP 1 PRO A 119 GLY A 120 0 7.87 CISPEP 2 SER A 220 PRO A 221 0 0.28 SITE 1 AC1 8 LEU A 90 LEU A 143 PHE A 159 MET A 162 SITE 2 AC1 8 GLY A 165 LEU A 212 ASP A 226 PHE A 227 CRYST1 105.111 105.111 72.198 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009514 0.005493 0.000000 0.00000 SCALE2 0.000000 0.010986 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013851 0.00000